Dr. Amy Meister, WeightWatchers' Chief Medical Officer, is part of the panel tackling this timely topic.
This session will delve into the groundbreaking world of GLP-1 drugs and examine tradeoffs between evidence, costs, and their potential value for both individual patients as well as the broader population.
Wednesday, June 12
8:45 am - 9:30 am PT
Allow us to (re)introduce ourselves
We're a full-spectrum weight-health platform that's built upon the best weight management behavior change program in the world with a fully integrated virtual clinic and medication management. Our platform provides individualized pathways and experiences—in real life and virtual—for members based on true clinical need.
What's next in weight health management?
Finding a complete and sustainable weight health management solution that includes cost containment for GLP-1 medications has never been more important.
Our comprehensive Buyer's Guide
has the information you need — all in one place.
-
Key criteria for assessing programs
-
A third-party vendor comparison
-
Questions to ask potential vendors
We can't wait to meet you.
We're here to be your organization's weight-health partner to improve the long-term health of your people while responsibly maximizing cost control.
